Conference
The Role of FDG-PET in Staging and Treatment for Stage III NSCLC in Ontario, Canada Between 2009-2017
Abstract
Purpose/Objective(s) Fluoro-2-deoxyglucose positron-emission tomography (PET) is now considered standard of care in the staging evaluation for new cases of stage III NSCLC however, there is not level 3 evidence demonstrating efficacy of PET. Using retrospective population-based data, we sought to examine the role and timing that PET scans play in influencing treatment choice, as well as survival in patients treated with chemoradiation (CRT) for …
Authors
Beers CA; Pond G; Wright J; Tsakiridis T; Okawara GS; Swaminath A
Volume
111
Publisher
Elsevier
Publication Date
November 2021
DOI
10.1016/j.ijrobp.2021.07.1224
Conference proceedings
International Journal of Radiation Oncology • Biology • Physics
Issue
3
ISSN
0360-3016